Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-06 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0001 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.16 | 0.0002 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |